Intratympanic gentamicin for Menière's disease: a meta-analysis.
about
Intratympanic gentamicin for Ménière's disease or syndromePharmacotherapy of vestibular and ocular motor disorders, including nystagmusCurrent treatment of vestibular, ocular motor disorders and nystagmusInner ear symptoms and disease: pathophysiological understanding and therapeutic optionsWhich medication do I need to manage dizzy patients?Intratympanic dexamethasone injections for refractory Meniere' s diseasePreclinical and clinical studies of unrelieved aural fullness following intratympanic gentamicin injection in patients with intractable Ménière's disease.One-shot, low-dosage intratympanic gentamicin for Ménière's disease: Clinical, posturographic and vestibular test findings.Temporal and spatial distribution of gentamicin in the peripheral vestibular system after transtympanic administration in guinea pigsSystemic aminoglycosides are trafficked via endolymph into cochlear hair cellsVestibular function and vertigo control after intratympanic gentamicin for Ménière's diseaseIntratympanic gentamicin treatment for Ménière's disease: a randomized, double-blind, placebo-controlled trial on dose efficacy - results of a prematurely ended study.In vitro and in vivo models of drug ototoxicity: studying the mechanisms of a clinical problem.New methods for diagnosis and treatment of vestibular diseases.A Pilot Study on the Efficacy of Continuous Positive Airway Pressure on the Manifestations of Ménière's Disease in Patients with Concomitant Obstructive Sleep Apnea Syndrome.Menière's disease: myths and realities.Understanding drug ototoxicity: molecular insights for prevention and clinical management.Gentamicin is primarily localized in vestibular type I hair cells after intratympanic administration.Evidence-based modification of intratympanic gentamicin injections in patients with intractable vertigoTranstympanic gentamicin treatment using Silverstein MicroWick in Ménière's disease patients: long term outcome.Evaluation of meta-analyses in the otolaryngological literature.Medical treatment of vestibular disorders.Intratympanic gentamicin treatment of patients with Ménière's disease with normal hearing.Hearing results and quality of life after streptomycin/dexamethasone perfusion for Meniere's disease.Variability in the perilymphatic diffusion of gadolinium does not predict the outcome of intratympanic gentamicin in patients with Ménière's disease.Biomedical engineering principles of modern cochlear implants and recent surgical innovations.Aminoglycoside therapy in infectious diseases.Intratympanic gentamicin for Meniere's disease: short- and long-term follow-up of two regimens of treatment.Management of intractable Ménière's disease after intratympanic injection of gentamicin.Is low-dose intratympanic gentamicin an effective treatment for Ménière's disease: the Birmingham experience.Is gentamycin delivery via sustained-release vehicles a safe and effective treatment for refractory Meniere's disease? A critical analysis of published interventional studies.Time course of repeated intratympanic gentamicin for Ménière's diseaseLongitudinal results with intratympanic dexamethasone in the treatment of Ménière's disease.Distribution of gentamicin in inner ear after local administration via a chitosan glycerophosphate hydrogel delivery system.Intratympanic gentamicin treatment 'as needed' for Meniere's disease. Long-term analysis using the Kaplan-Meier method.Intratympanic gentamicin therapy for intractable Ménière's disease.Partial Aminoglycoside Lesions in Vestibular Epithelia Reveal Broad Sensory Dysfunction Associated with Modest Hair Cell Loss and Afferent Calyx Retraction.Hearing results following intratympanic gentamicin perfusion for Ménière's disease.Surgery for vertigo: 10-year audit from a contemporary vertigo clinic.Molecular mechanisms involved in cochlear implantation trauma and the protection of hearing and auditory sensory cells by inhibition of c-Jun-N-terminal kinase signaling.
P2860
Q24235857-FA17D69F-4F78-455A-8F47-B5030F1BA96BQ24595123-AAD65053-06D1-4236-99C1-97E35C1185A3Q24628964-1AD1F2A0-39D3-449B-B2F2-3252A0A2A0EEQ26997318-E1ACF84A-07F8-41CD-8729-607584C62553Q28300141-76AAC593-A714-467B-B25D-EC4A872C9B67Q30408145-4334C3B2-928D-41AB-8BF5-C7B56AC4BAF2Q30432163-14C75DEF-8FA1-4BB8-9B5C-54E6C76905B0Q30438903-EEF81CD0-1481-41CA-BA9B-0B536C316C0CQ30440769-144F4532-6095-480A-A2D4-1034F667819CQ30472015-10385A80-7BBE-455A-BF24-89E94EE9538BQ33646604-A496AA01-5BCC-4DC8-B62C-E45A583B42A5Q34076625-C29BFEA2-BD15-438E-B71E-38E8D729F5D1Q34224262-4E889067-FC4C-4953-B8A1-B6EFE8C0014FQ34344253-CF188371-6311-4489-A69E-3F9EC8E37CC8Q36090652-ECB63E7B-68ED-4283-87FC-57FF64AE1A2AQ36275176-8A53DA77-167C-4B90-A9F6-618B99DB1788Q36446895-1084C476-3F73-4419-AF96-168AD5104F64Q36881488-8740ABCF-EA01-46C1-9203-7A0F53145D1EQ36905893-2579D549-6137-4640-AC62-B06AA791F63EQ37183171-F6763FEA-6A1E-486F-A7F8-7283E9BFD9D5Q37227360-E07BC7B6-A626-4DA5-B990-B8C0F0A8F2F4Q37519697-A28C9C09-8432-4013-B34B-DA4309776940Q37715425-D8F52B98-A013-401E-AC42-F2C2800E78B5Q37970006-326DF155-D0DC-4C49-9B57-226ECA4CC75CQ37989132-2722A3C3-9937-48DF-935C-82651C452DA7Q38050338-E42FD36A-D77C-4DB5-94A4-4221822C4BB1Q38112810-D04738A6-A839-421D-A831-784CC16D9334Q38183310-2AC513D0-4904-46C6-917F-F170B8A25EF0Q38264361-BA2B28CE-3B7A-479F-B441-EEE292392680Q38578300-E1DF40BC-10FB-4036-AC28-D861C623D3DEQ38953398-0D1DB211-2400-4181-8A8D-0C728DC679E6Q41872338-CFFE23AA-A74E-4599-A5BD-2E8124BAC339Q42428540-00C87F80-AB33-4CBE-A4A0-9AEA4F6018B4Q42505354-138FDF6C-D57A-4951-AC6B-CB91D0B7BE3DQ43574665-4CEF017B-4578-4FB0-8406-A4BBBC7420FDQ44247121-B32402A8-9CD0-49D8-8644-D839F9A61BBEQ44557248-D92F67FD-3409-4985-99C0-9D141CB1DE4FQ44942464-6EF349DF-FA5D-48C5-ACDB-CEE122DD6B88Q47887158-6FE10755-D94E-4C3D-9420-F937473420FDQ48176732-4A421D21-70F9-4DA8-A0BF-C2A3EAD97E11
P2860
Intratympanic gentamicin for Menière's disease: a meta-analysis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Intratympanic gentamicin for Menière's disease: a meta-analysis.
@ast
Intratympanic gentamicin for Menière's disease: a meta-analysis.
@en
type
label
Intratympanic gentamicin for Menière's disease: a meta-analysis.
@ast
Intratympanic gentamicin for Menière's disease: a meta-analysis.
@en
prefLabel
Intratympanic gentamicin for Menière's disease: a meta-analysis.
@ast
Intratympanic gentamicin for Menière's disease: a meta-analysis.
@en
P2093
P1433
P1476
Intratympanic gentamicin for Menière's disease: a meta-analysis.
@en
P2093
Eran Kozer
Gideon Koren
John A Rutka
Raanan Cohen-Kerem
Thomas R Einarson
Vitaly Kisilevsky
P304
P356
10.1097/01.MLG.0000149439.43478.24
P407
P577
2004-12-01T00:00:00Z